1. Korbecki, Jan, Kojder, Klaudyna, Kapczuk, Patrycja, Chlubek, Dariusz, Baranowska-Bosiacka, Irena. 2021. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature. In International journal of molecular sciences, 22, . doi:10.3390/ijms22020843. https://pubmed.ncbi.nlm.nih.gov/33467722/
2. Lu, Guangyu, Ma, Xiaotong, Wang, Fei, Liu, Wei, Li, Yanyan. 2023. Effect of CXCL17 on Subcutaneous Preadipocytes Proliferation in Goats. In Animals : an open access journal from MDPI, 13, . doi:10.3390/ani13111757. https://pubmed.ncbi.nlm.nih.gov/37889664/
3. Hernández-Ruiz, Marcela, Zlotnik, Albert. . Mucosal Chemokines. In Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 37, 62-70. doi:10.1089/jir.2016.0076. https://pubmed.ncbi.nlm.nih.gov/28207301/
4. Ocón, Borja, Xiang, Menglan, Bi, Yuhan, Pan, Junliang, Butcher, Eugene C. 2024. A lymphocyte chemoaffinity axis for lung, non-intestinal mucosae and CNS. In Nature, 635, 736-745. doi:10.1038/s41586-024-08043-2. https://pubmed.ncbi.nlm.nih.gov/39293486/
5. Hernández-Ruiz, Marcela, Othy, Shivashankar, Herrera, Carolina, Cahalan, Michael D, Zlotnik, Albert. 2019. Cxcl17-/- mice develop exacerbated disease in a T cell-dependent autoimmune model. In Journal of leukocyte biology, 105, 1027-1039. doi:10.1002/JLB.3A0918-345RR. https://pubmed.ncbi.nlm.nih.gov/30860634/
6. Kaya, Berna, Melhem, Hassan, Niess, Jan Hendrik. 2021. GPR35 in Intestinal Diseases: From Risk Gene to Function. In Frontiers in immunology, 12, 717392. doi:10.3389/fimmu.2021.717392. https://pubmed.ncbi.nlm.nih.gov/34790192/
7. Wang, Linpei, Li, Haitao, Zhen, Zuojun, Zeng, Huahuo, Li, Li. 2018. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma. In Gene, 690, 129-136. doi:10.1016/j.gene.2018.12.043. https://pubmed.ncbi.nlm.nih.gov/30597237/
8. Li, Li, Yan, Jing, Xu, Jing, Zheng, Limin, Lau, Wan Yee. 2014. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. In PloS one, 9, e110064. doi:10.1371/journal.pone.0110064. https://pubmed.ncbi.nlm.nih.gov/25303284/